(Q40968069)

English

Evidence for proteasome involvement in polyglutamine disease: localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro

scientific article published on April 1999

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

Evidence for proteasome involvement in polyglutamine disease: localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

author name string

Y Chai

1

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

S L Koppenhafer

2

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

S J Shoesmith

3

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

M K Perez

4

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

H L Paulson

5

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

publication date

1 April 1999

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

Human Molecular Genetics

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

673-682

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

The CAG/polyglutamine tract diseases: gene products and molecular pathogenesis

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2F8.4.673

21 January 2018

Polyglutamines, nuclear inclusions and neurodegeneration

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2F8.4.673

21 January 2018

Glutamine repeats as polar zippers: their possible role in inherited neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2F8.4.673

21 January 2018

Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2F8.4.673

21 January 2018

Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2F8.4.673

21 January 2018

Are neuronal intranuclear inclusions the common neuropathology of triplet-repeat disorders with polyglutamine-repeat expansions?

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2F8.4.673

21 January 2018

Expanded polyglutamine protein forms nuclear inclusions and causes neural degeneration in Drosophila

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2F8.4.673

21 January 2018

Spinocerebellar ataxia type 7 (SCA7): a neurodegenerative disorder with neuronal intranuclear inclusions

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2F8.4.673

21 January 2018

Nuclear inclusions of the androgen receptor protein in spinal and bulbar muscular atrophy

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2F8.4.673

21 January 2018

The ubiquitin-proteasome proteolytic pathway

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2F8.4.673

21 January 2018

The ubiquitin pathway in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2F8.4.673

21 January 2018

Genetic classification of primary neurodegenerative disease

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2F8.4.673

21 January 2018

Protein precipitation: a common etiology in neurodegenerative disorders?

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2F8.4.673

21 January 2018

Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1.

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2F8.4.673

21 January 2018

CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2F8.4.673

21 January 2018

Joseph disease: a multisystem degenerative disorder of the nervous system

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2F8.4.673

21 January 2018

An isoform of ataxin-3 accumulates in the nucleus of neuronal cells in affected brain regions of SCA3 patients.

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2F8.4.673

21 January 2018

Recruitment and the role of nuclear localization in polyglutamine-mediated aggregation

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2F8.4.673

21 January 2018

Editing of ubiquitin conjugates by an isopeptidase in the 26S proteasome

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2F8.4.673

21 January 2018

Machado-Joseph disease gene product is a cytoplasmic protein widely expressed in brain

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2F8.4.673

21 January 2018

Ataxin-1 with an expanded glutamine tract alters nuclear matrix-associated structures

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2F8.4.673

21 January 2018

Structure and Function in the Nucleus

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2F8.4.673

21 January 2018

Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2F8.4.673

21 January 2018

Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions.

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2F8.4.673

21 January 2018

Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2F8.4.673

21 January 2018

PML induces a novel caspase-independent death process

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2F8.4.673

21 January 2018

PML is essential for multiple apoptotic pathways

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2F8.4.673

21 January 2018

Expression analysis of the ataxin-1 protein in tissues from normal and spinocerebellar ataxia type 1 individuals

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2F8.4.673

21 January 2018

Expanded polyglutamine in the Machado-Joseph disease protein induces cell death in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2F8.4.673

21 January 2018

Ataxin-3 is transported into the nucleus and associates with the nuclear matrix

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2F8.4.673

21 January 2018

Machado-Joseph disease gene product identified in lymphocytes and brain

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2F8.4.673

21 January 2018

Pathological lesions of Alzheimer's disease and dementia with Lewy bodies brains exhibit immunoreactivity to an ATPase that is a regulatory subunit of the 26S proteasome

1 reference

https://api.crossref.org/works/10.1093%2FHMG%2F8.4.673

21 January 2018

Identifiers

10.1093/HMG/8.4.673

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40968069&oldid=1911290852"